Skip to content

The associations of disease characteristics and short-term prognosis in patients with ST segment elevation myocardial infarction

Study for the Impact of Accelerating the Construction and Promotion of the Chest Pain Center in Chongqing on the Diagnosis and Prognosis of Acute Myocardial Infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028516
Enrollment
Unknown
Registered
2019-12-25
Start date
2015-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST segment elevation myocardial infarction

Interventions

Sponsors

Yuzhong District Science and Technology Commission
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of STEMI was defined as chest pain lasting for >30 minutes; 2. persistent ST-segment elevation (>0.1 mV in at least 2 contiguous extremity leads or >0.2 mV in at least 2 contiguous precordial leads) or new-onset bundle branch block; 3. sharply elevated biomarkers of troponin I or creatine kinase-MB; 4. the chest pain last no more than 24 hours.

Exclusion criteria

Exclusion criteria: 1. patients admitted at >24 hours from symptom onset; 2. patients who could not be contacted to confirm survival during long-term follow-up; 3. patients with prior pacemaker implantation; 4. patients with pregnancy; 5. patients without complete data.

Design outcomes

Primary

MeasureTime frame
death;

Countries

China

Contacts

Public ContactLuo Suxin

The First Affiliated Hospital of Chongqing Medical University

luosuxin@hospital.cqmu.edu.cn+86 023 89011565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026